Development of antibodies for detection of ERCC1 overexpression, a possible biomarker for cisplatin resistance of cancer

被引：0
|
作者：
Oishi, Takayuki [1 ]
Sasaki, Yuka [1 ]
Fujimori, Hiroaki [1 ]
Shibata, Noriko
Iwasa, Satoru
Nakao, Kazuhiko
Yamada, Yasuhide
Hiraoka, Nobuyoshi
Masutani, Mitsuko [1 ]
机构：
[1] Nagasaki Univ, Grad Sch, Dept Frontier Life Sci, Nagasaki, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
ERCC1;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-3371
引用
收藏
页码：1148 / 1148
页数：1
相关论文
共 50 条
  • [41] Is ERCC1 a reliable prognostic protein biomarker in non-small-cell lung cancer?
    Durrington, Hannah J.
    THORAX, 2014, 69 (04) : 345 - 345
  • [42] Evaluation of ERCC1 Expression for Cisplatin Sensitivity in Human Hepatocellular Carcinoma
    Shigeru Ueda
    Ken Shirabe
    Kazutoyo Morita
    Kenji Umeda
    Hiroto Kayashima
    Hideaki Uchiyama
    Yuji Soejima
    Akinobu Taketomi
    Yoshihiko Maehara
    Annals of Surgical Oncology, 2011, 18 : 1204 - 1211
  • [43] Evaluation of ERCC1 Expression for Cisplatin Sensitivity in Human Hepatocellular Carcinoma
    Ueda, Shigeru
    Shirabe, Ken
    Morita, Kazutoyo
    Umeda, Kenji
    Kayashima, Hiroto
    Uchiyama, Hideaki
    Soejima, Yuji
    Taketomi, Akinobu
    Maehara, Yoshihiko
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (04) : 1204 - 1211
  • [44] A new step ahead for the consideration of ERCC1 as a candidate biomarker to select NSCLC patients for the treatment of cetuximab in combination with cisplatin
    Olaussen, Ken Andre
    CANCER BIOLOGY & THERAPY, 2009, 8 (20) : 1922 - 1923
  • [45] The association of Snail expression with ERCC1 and beta-tubulin class III expression in cisplatin and paclitaxel resistance of lung cancer cells
    Hung, Jung-Jyh
    Wu, Kou-Juey
    CANCER RESEARCH, 2012, 72
  • [46] ERCC1 predicts outcome in patients with gastric cancer treated with adjuvant cisplatin-based chemotherapy
    Sara De Dosso
    Elena Zanellato
    Martina Nucifora
    Renzo Boldorini
    Angelica Sonzogni
    Roberto Biffi
    Nicola Fazio
    Eraldo Bucci
    Ottavio Beretta
    Stefano Crippa
    Piercarlo Saletti
    Milo Frattini
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 159 - 165
  • [47] Sunitinib synergizes the antitumor effect of cisplatin via modulation of ERCC1 expression in models of gastric cancer
    Yoon, Young-Kwang
    Im, Seock-Ah
    Min, Ahrum
    Kim, Hwang-Phill
    Hur, Hyung-Seok
    Lee, Kyung-Hun
    Han, Sae-Won
    Song, Sang-Hyun
    Oh, Do Youn
    Kim, Tae-You
    Kim, Woo Ho
    Bang, Yung-Jue
    CANCER LETTERS, 2012, 321 (02) : 128 - 136
  • [48] Predictive and Prognostic Values of Tau and ERCC1 in Advanced Breast Cancer Patients Treated with Paclitaxel and Cisplatin
    Shao, Yu-Yun
    Kuo, Kuan-Ting
    Hu, Fu-Chang
    Lu, Yen-Shen
    Huang, Chiun-Sheng
    Liau, Jau-Yu
    Lee, Wei-Chung
    Hsu, Chiun
    Kuo, Wun-Hon
    Chang, King-Jeng
    Lin, Ching-Hung
    Cheng, Ann-Lii
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (04) : 286 - 293
  • [49] ERCC1 predicts outcome in patients with gastric cancer treated with adjuvant cisplatin-based chemotherapy
    De Dosso, Sara
    Zanellato, Elena
    Nucifora, Martina
    Boldorini, Renzo
    Sonzogni, Angelica
    Biffi, Roberto
    Fazio, Nicola
    Bucci, Eraldo
    Beretta, Ottavio
    Crippa, Stefano
    Saletti, Piercarlo
    Frattini, Milo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (01) : 159 - 165
  • [50] SNPs in ERCC1 and drug response to cisplatin in non-small-cell lung cancer patients
    Osawa, Kayo
    PHARMACOGENOMICS, 2011, 12 (04) : 445 - 447
12345